1 |
Yuqing M, Shang G, Qing G, Jiyang W, Ruihao L, Zuoguan C, Yongpeng D, Zhiyuan W, Yongjun L. Transcriptome profiling of abdominal aortic tissues reveals alterations in mRNAs of Takayasu arteritis. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1036233] [Reference Citation Analysis]
|
2 |
Misra DP, Jain N, Ora M, Singh K, Agarwal V, Sharma A. Outcome Measures and Biomarkers for Disease Assessment in Takayasu Arteritis. Diagnostics (Basel) 2022;12:2565. [PMID: 36292253 DOI: 10.3390/diagnostics12102565] [Reference Citation Analysis]
|
3 |
Liu L, Chen J, Li J, Yang Y, Zeng X, Tian X. Whole Exome Sequencing Revealed Variants That Predict Pulmonary Artery Involvement in Patients with Takayasu Arteritis. J Inflamm Res 2022;15:4817-31. [PMID: 36046661 DOI: 10.2147/JIR.S377402] [Reference Citation Analysis]
|
4 |
Danda D, Manikuppam P, Tian X, Harigai M. Advances in Takayasu arteritis: An Asia Pacific perspective. Front Med 2022;9. [DOI: 10.3389/fmed.2022.952972] [Reference Citation Analysis]
|
5 |
Watanabe R, Hashimoto M. Pathogenic role of monocytes/macrophages in large vessel vasculitis. Front Immunol 2022;13:859502. [DOI: 10.3389/fimmu.2022.859502] [Reference Citation Analysis]
|
6 |
Watanabe R, Hashimoto M. Vasculitogenic T Cells in Large Vessel Vasculitis. Front Immunol 2022;13:923582. [DOI: 10.3389/fimmu.2022.923582] [Reference Citation Analysis]
|
7 |
Watanabe R, Hashimoto M. Perspectives of JAK Inhibitors for Large Vessel Vasculitis. Front Immunol 2022;13:881705. [PMID: 35432355 DOI: 10.3389/fimmu.2022.881705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|